Research Collaboration between Harvard Medical School and the HAWK in Göttingen

Publizierungsdatum: 17.05.2023

Novel findings from researchers at the Brigham and Women's Hospital and Harvard Medical School, in collaboration with the Health Campus Göttingen contradict previous notions about sugar's role in the onset of diabetic cataracts.

The team of researchers, led by Prof. Dr. Ali Hafezi-Moghadam, Director of the Molecular Biomarkers Nano-Imaging Laboratory (MBNI), in collaboration with Professor Dr. Christoph Rußmann, Dean of the Health Campus and a Visiting Professor at MBNI, found early signs of damage in the eye before the onset of type 2 diabetes, suggesting that diabetic complications may start during the pre-diabetic state. The team has published the results in the Journal of Biomedical Science.

“For over half a century, the sugar hypothesis provided an explanation for how the lens becomes opaque, when the blood sugar in an animal is experimentally raised." said Hafezi-Moghadam, "but this does not have to be how things work in human cataracts.”To unravel the origins of tissue damage in diabetes, Hafezi-Moghadam’s team broke tradition with the existing models. Instead, it conducted it’s studies in the Nile grass rat, a model that they originally reported spontaneously develops type 2 diabetes when kept in captivity and closely mimics the condition in humans. In addition, “the advanced imaging technology we used in this study” said Rußmann “helped us see for the first time dot-like microlesions that would not have been visible otherwise. This is where advanced medical technology helps bring novel mechanistic insights.”

 

The newly found micro-lesions preceded all forms of diabetic cataract. But unexpectedly in nearly half of the animals, the micro-lesions appeared before the animals entered hyperglycemia, or high blood sugar. “It became clear that there was more complexity than the sugar hypothesis was able to explain” said Dr. Ehsan Ranaei Pirmaradan, the first author of the study and a postdoctoral fellow at MBNI and Harvard Medical School. “We found immune cells in the vicinity of the lens and in the lens capsule. That drew our focus to a completely new direction.”  

The researchers identified that immune cells migrated from specialized structures in the eye called the ciliary bodies toward the lens. In these areas, where the immune cells traversed the capsule of the lens, they found that the epithelial cells that normally cover the inner surface of the lens capsule changed their identity and behaved differently. These changes, also referred to as epithelial-mesenchymal transformation (EMT), were followed by seemingly unorganized cell growth, cell death, and cell migrations into the body of the lens. In some regions, the newly transformed cells simply vacated their original positions and made their way into the lens.

“While cataracts today are easily removable with surgery, this procedure comes with the risk of complications” said Hafezi-Moghadam. “With over 500 million people worldwide having diabetes, there is an urgent need for trying to find non-surgical ways of preventing, slowing, or even reversing this complication. Perhaps one day it will become possible to avoid performing these surgeries altogether. And that requires that we return to the basics.”

https://www.hawk.de/en/news-portal/press-releases/role-immune-cells-early-diabetic-cataract-development